Medicines in Development for Osteoporosis 2016 Report

Nearly 54 million adults in the United States have either osteoporosis or low bone density, according to the National Osteoporosis Foundation.

America's biopharmaceutical research companies are developing nine medicines for the treatment of osteoporosis.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.